|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
16 December 2017 |
|
Main ID: |
NCT03362762 |
|
Date of registration:
|
27/11/2017 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Characteristics of Type 2 Diabetes Patients, Treated With Insulin and Their Follow up Care in Guadeloupe
DT2IT |
|
Scientific title:
|
Characteristics of Type 2 Diabetes Patients, Treated With Insulin and Their Follow up Care in Guadeloupe |
|
Date of first enrolment:
|
December 16, 2013 |
|
Target sample size:
|
205 |
|
Recruitment status: |
Completed |
|
URL:
|
https://clinicaltrials.gov/show/NCT03362762 |
|
Study type:
|
Observational |
|
Study design:
|
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
Guadeloupe
| | | | | | | |
|
Contacts
|
|
Name:
|
Pauline NOUVIER KANGAMBEGA, medicine degree, diabetes |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Hospital University Center of Pointe-à-Pitre |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Men or woman
- Age = 18 years old
- Patient with type 2 diabetes, treated with insulin for at least one year
- Patient accepting to participate to the study
Exclusion Criteria:
• Pregnant or breastfeeding woman
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
|
Health Condition(s) or Problem(s) studied
|
|
Type 2 Diabetes Treated With Insulin
|
|
Intervention(s)
|
|
Other: Description of plans insuliniques used in Guadeloupe in the type 2 diabetes and the characteristics of the handled patients:
|
|
Primary Outcome(s)
|
|
Characteristic of type 2 diabetes patients, treated with insulin in Guadeloupe
[Time Frame: Trough study completion, an average of 2 years]
|
|
Secondary Outcome(s)
|
|
Describe the relation between the rate of HbAC and the plan of insulinothérapie
[Time Frame: Trough study completion, an average of 2 years]
|
|
Secondary ID(s)
|
|
RNI-PAP-913379
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|